Impact of intrarectal chromofungin treatment on dendritic cells-related markers in different immune compartments in colonic inflammatory conditions
Authors:
Open Access
- 21 December 2021
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 27 (47) , 8138-8155
Abstract
Impact of intrarectal chromofungin treatment on dendritic cells-related markers in different immune compartments in colonic inflammatory conditionsKeywords
This publication has 73 references indexed in Scilit:
- Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signallingBritish Journal of Nutrition, 2013
- Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathwaysNature Immunology, 2012
- CD80 and CD86 Differentially Regulate Mechanical Interactions of T-Cells with Antigen-Presenting Dendritic Cells and B-CellsPLOS ONE, 2012
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011
- Pro-inflammatory Cytokine Expression of Spleen Dendritic Cells in Mouse ToxoplasmosisThe Korean Journal of Parasitology, 2011
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and AktInternational Journal of Cancer, 2009
- Two Chromogranin A-Derived Peptides Induce Calcium Entry in Human Neutrophils by Calmodulin-Regulated Calcium Independent Phospholipase A2PLOS ONE, 2009
- CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naïve and antigen-primed T cellsBMC Immunology, 2008
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007